epigallocatechin gallate has been researched along with Adenoma, Prostatic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korkmaz, M; Soya, E; Tepedelen, BE | 1 |
| Chen, J; Lei, Y; Zhou, J; Zhou, X | 1 |
| Gasiewicz, TA; Henry, EC; Moses, MA; Ricke, WA | 1 |
| Chen, J; Song, H | 1 |
| Liao, S | 1 |
1 review(s) available for epigallocatechin gallate and Adenoma, Prostatic
| Article | Year |
|---|---|
The medicinal action of androgens and green tea epigallocatechin gallate.
Topics: Androgens; Animals; Catechin; Complementary Therapies; Female; Humans; Male; Medicine, East Asian Traditional; Phytotherapy; Plant Extracts; Prostatic Hyperplasia; Prostatic Neoplasms; Sensitivity and Specificity; Tea | 2001 |
4 other study(ies) available for epigallocatechin gallate and Adenoma, Prostatic
| Article | Year |
|---|---|
Epigallocatechin-3-gallate reduces the proliferation of benign prostatic hyperplasia cells via regulation of focal adhesions.
Topics: Actin Cytoskeleton; Actins; Anticarcinogenic Agents; Catechin; Cell Line; Cell Movement; Cell Proliferation; Cell Survival; Focal Adhesions; Humans; Male; Prostatic Hyperplasia | 2017 |
Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats.
Topics: Animals; Catechin; Collagen; Epithelial-Mesenchymal Transition; Fibrosis; Male; MicroRNAs; Oxidative Stress; Prostate; Prostatic Hyperplasia; Rats; Rats, Wistar; Receptors, Androgen; Receptors, Estrogen; Smad3 Protein; Testosterone; Transforming Growth Factor beta1 | 2018 |
The heat shock protein 90 inhibitor, (-)-epigallocatechin gallate, has anticancer activity in a novel human prostate cancer progression model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Catechin; Cell Movement; Cell Proliferation; Disease Progression; HSP90 Heat-Shock Proteins; Humans; Male; Mice; Prostatic Hyperplasia; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Wound Healing; Xenograft Model Antitumor Assays | 2015 |
Protective potential of epigallocatechin-3-gallate against benign prostatic hyperplasia in metabolic syndrome rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Catechin; Cytokines; Disease Models, Animal; Male; Metabolic Syndrome; Oxidative Stress; Peroxisome Proliferator-Activated Receptors; Prostatic Hyperplasia; Rats, Sprague-Dawley; Somatomedins | 2016 |